We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
4026
Autolus Therapeutics
AUTL
$588M
$17K ﹤0.01%
2,586
-494
-16% -$3.07K
AVD icon
4027
American Vanguard Corp
AVD
$63.2M
$17K ﹤0.01%
995
-4,776
-83% -$90.7K
AXDX
4028
DELISTED
Accelerate Diagnostics
AXDX
$17K ﹤0.01%
208
-580
-74% -$46.1K
BKKT icon
4029
Bakkt Inc
BKKT
$327M
$17K ﹤0.01%
68
+60
+750% +$16.5K
BXC icon
4030
BlueLinx
BXC
$719M
$17K ﹤0.01%
+335
New +$16.5K
CIA icon
4031
Citizens
CIA
$187M
$17K ﹤0.01%
3,135
-5,365
-63% -$29.5K
CRWS icon
4032
Crown Crafts
CRWS
$32.3M
$17K ﹤0.01%
2,287
+1,703
+292% +$13.2K
DCTH icon
4033
Delcath Systems
DCTH
$599M
$17K ﹤0.01%
+1,335
New +$15.3K
DLB icon
4034
Dolby
DLB
$5.79B
$17K ﹤0.01%
174
-5,132
-97% -$507K
ETWO
4035
DELISTED
E2open Parent Holdings
ETWO
$17K ﹤0.01%
+1,480
New +$17K
EYPT icon
4036
EyePoint Inc
EYPT
$1.08B
$17K ﹤0.01%
1,929
-2,196
-53% -$21.1K
FBIO icon
4037
Fortress Biotech
FBIO
$88M
$17K ﹤0.01%
312
-594
-66% -$35.8K
FMX icon
4038
Fomento Económico Mexicano
FMX
$40.1B
$17K ﹤0.01%
207
-232
-53% -$19K
FORR icon
4039
Forrester Research
FORR
$224M
$17K ﹤0.01%
370
-1,367
-79% -$59K
FULC icon
4040
Fulcrum Therapeutics
FULC
$283M
$17K ﹤0.01%
1,653
+633
+62% +$6.4K
FUN icon
4041
Cedar Fair
FUN
$1.67B
$17K ﹤0.01%
388
-6,004
-94% -$284K
HEFA icon
4042
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.76B
$17K ﹤0.01%
+500
New +$17K
IMA
4043
ImageneBio Inc
IMA
$64.2M
$17K ﹤0.01%
+102
New +$22.5K
LMND icon
4044
Lemonade
LMND
$4.06B
$17K ﹤0.01%
157
-428
-73% -$38.9K
LPTH icon
4045
Lightpath Technologies
LPTH
$787M
$17K ﹤0.01%
6,720
+5,006
+292% +$13.2K
LQDA icon
4046
Liquidia Corp
LQDA
$8B
$17K ﹤0.01%
5,922
-9,184
-61% -$25.4K
NRIM icon
4047
Northrim BanCorp
NRIM
$594M
$17K ﹤0.01%
1,604
-1,476
-48% -$16.1K
ONTF
4048
DELISTED
ON24
ONTF
$17K ﹤0.01%
487
-253
-34% -$9.89K
PLBC icon
4049
Plumas Bancorp
PLBC
$430M
$17K ﹤0.01%
531
+135
+34% +$3.94K
SJ icon
4050
Scienjoy Holding
SJ
$34.8M
$17K ﹤0.01%
+2,791
New +$22.8K
160 161
162
163 164

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.